We are building Definium to be a leader in psychiatry, focused on delivering a differentiated, scalable franchise for patients with depression, anxiety, and trauma, anchored by DT120 ODT, which we ...
Detailed price information for Definium Therapeutics Inc (DFTX-Q) from The Globe and Mail including charting and trades.
Kraken parent Payward to buy Bitnomial for up to $550M, adding CFTC-licensed crypto derivatives (perps, options).
Charenton-le-Pont, 16 April 2026 2025 full-year earnings Resilient results despite a sharp slowdown in the global spirits market and some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results